Generex Biotechnology Corporation (NASDAQ: GNBT), a leader in the area of buccal drug delivery, announced today that it made two poster presentations of clinical data at the 33rd Annual Meeting & Exposition of the Controlled Release Society in Vienna, Austria, July 22 - 26, 2006. The data relates to Generex Oral-lyn™, the Company's proprietary oral insulin spray product, and to Generex Metformin Gum, a proprietary alternative delivery format for metformin under development by Generex in collaboration with Fertin Pharma A/S.
